Drugs / VISION5 Product
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01943721 | Oct 2013 → Jun 2014 | ocular hypertension, open-angle glaucoma | ForSight Vision5, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VISION5 Product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01943721 ↗ |